2022
DOI: 10.1111/codi.16086
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian transposition in rectal cancer: uncertain benefit at a high price

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 22 publications
(17 reference statements)
0
1
0
Order By: Relevance
“…Median ovarian survival was 76 months and only one patient developed isolated ovarian metastasis after 23 months that required a surgical salvage. However, there are some doubts and criticisms regarding indications of the procedure being oncologically unsafe given the risk of ovarian relapses [2]. Undoubtedly, a risk-benefit evaluation must be carried out before offering any procedure.…”
mentioning
confidence: 99%
“…Median ovarian survival was 76 months and only one patient developed isolated ovarian metastasis after 23 months that required a surgical salvage. However, there are some doubts and criticisms regarding indications of the procedure being oncologically unsafe given the risk of ovarian relapses [2]. Undoubtedly, a risk-benefit evaluation must be carried out before offering any procedure.…”
mentioning
confidence: 99%